Senior Scientific and Business Development Director @ PBL Biomedical Laboratories/PBL InterferonSource (January 2007 - January 2008)
Director, Drug Discovery and Development @ PBL Therapeutics (January 2002 - January 2006)
Section Head, Protein Biochemistry and Purification @ PBL Therapeutics (January 2000 - January 2002)
Senior Staff Scientist @ (January 1998 - January 1999)
Postdoctoral Fellow @ (January 1995 - January 1998)
PRAT Postdoctoral Fellow @ National Institutes of Health, National Institute of Mental Health (January 1993 - January 1995)
Chemist, New Product Development @ Lehn & Fink Products Corp./Sterling Drug Inc. (January 1983 - January 1986)
Bill Clark Education
Yale School of Medicine
Ph.D. (Pharmacology)
1989-1993
Yale School of Medicine
M. Phil. (Pharmacology)
1986-1989
Boston College
B.S. (Chemistry)
1979-1983
Bergen Catholic High School 1975-1979
Bill Clark Skills
Business Development
In-licensing
Out-licensing
Strategic Alliances
Lifesciences
Biotechnology
Pharmacology
Assay Development
Product Development
Protein Purification
ELISA
GPCRs
Cytokines
Neuroscience
Biochemistry
Molecular Biology
Recombinant DNA Technology
Recombinant Protein Expression
Monoclonal Antibodies
Cell Culture
Protein Expression
Life Sciences
Pharmaceutical Industry
Management
Teaching
In Licensing
Strategy
Immunology
Science
Out Licensing
HPLC
Analytical Chemistry
Sales
Drug Discovery
Bill Clark Summary
Bill Clark, based in Piscataway Township, NJ, US, is currently a Vice President, Science and Strategic Alliances at PBL Assay Science / PBL Biomedical Laboratories. Bill Clark brings experience from previous roles at PBL Biomedical Laboratories/PBL InterferonSource, PBL Therapeutics and The National Institutes of Health. Bill Clark holds a 1989 - 1993 Ph.D. in Pharmacology @ Yale School of Medicine. With a robust skill set that includes Business Development, In-licensing, Out-licensing, Strategic Alliances, Lifesciences and more. Bill Clark has 1 emails on RocketReach.
Looking for a different Bill Clark?
Find contact details for 700 million professionals.